In a New Audio Interview at SmallCapVoice.com, PositiveID Corporation Discusses Its Recently Announced Revenue Guidance of $4...
June 11 2014 - 8:00AM
SmallCapVoice.com, Inc. announced today that a new audio interview
with PositiveID Corporation ("PositiveID" or the "Company")
(OTCQB:PSID), a developer of biological detection and diagnostics
solutions, is now available. The interview can be heard at
http://smallcapvoice.com/blog/6-9-14-smallcapvoice-interview-with-positiveid-corp-psid.
PositiveID's Chairman and Chief Executive Officer, William J.
Caragol, called in to SmallCapVoice.com to discuss the Company's
recent announcement of its first-ever revenue guidance of $4-10
million, $3.3 million of which is already in backlog, over the next
18 months. During the interview Mr. Caragol also describes how a
pick-up in U.S. government bio-threat detection research and
development as well as procurements are providing the Company with
increased business opportunities.
SmallCapVoice.com is a recognized corporate investor relations
firm, with clients nationwide, known for its ability to help
emerging growth companies build a following among retail and
institutional investors. SmallCapVoice.com utilizes its stock
newsletter to feature its daily stock picks, audio interviews, as
well as its clients' financial news releases. SmallCapVoice.com
also offers individual investors all the tools they need to make
informed decisions about the stocks they are interested in. Tools
like stock charts, stock alerts, and Company Information Sheets can
assist with investing in stocks that are traded on the OTC BB and
Pink Sheets. To learn more about SmallCapVoice.com and their
services, please visit
http://www.smallcapvoice.com/services.html.
About PositiveID Corporation
PositiveID Corporation is an emerging growth company and
developer of biological detection systems for America's homeland
defense industry as well as rapid biological testing. PositiveID is
focused on the development of microfluidic systems for the
automated preparation of and performance of biological assays in
order to detect biological threats and analyze biological samples.
For more information on PositiveID, please visit
http://www.PositiveIDCorp.com.
Statements about PositiveID's future expectations, including
without limitation, the likelihood that PositiveID will generate
revenue of $4-10 million, $3.3 million of which is already in
backlog, over the next 18 months; constitute "forward-looking
statements" within the meaning of Section 27A of the Securities Act
of 1933, Section 21E of the Securities Exchange Act of 1934, and as
that term is defined in the Private Litigation Reform Act of 1995.
Such forward-looking statements involve risks and uncertainties,
including the likelihood that PositiveID will be successful with
its submissions for bids and proposals in response to a pick-up in
new U.S. government procurements for bio-threat detection, and are
subject to change at any time, and PositiveID's actual results
could differ materially from expected results. Additional
information about these and other factors that could affect the
Company's business is set forth in the Company's various filings
with the Securities and Exchange Commission, including those set
forth in the Company's 10-K filed on April 11, 2014, and 10-Qs
filed on May 20, 2014, November 19, 2013, and August 14, 2013, as
amended August 19, 2013, under the caption "Risk Factors." The
Company undertakes no obligation to update or release any revisions
to these forward-looking statements to reflect events or
circumstances after the date of this statement or to reflect the
occurrence of unanticipated events, except as required by law.
Contact: PositiveID Corporation Allison Tomek 561-805-8000
atomek@positiveidcorp.com
Contact for SmallCapVoice.com:
Stuart T. Smith 512-267-2430 info@smallcapvoice.com